Business Wire

WA-SPIE

12.1.2021 18:11:31 CET | Business Wire | Press release

Share
SPIE, The International Society for Optics and Photonics, Announces Its 2021 Society Awards

The Awards Committee of SPIE, the international society for optics and photonics , today announced the recipients of its prestigious annual awards . Honoring transformative advancements in multiple areas — including medicine, astronomy, lithography, optical metrology, and community-focused achievements — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210112005279/en/

SPIE Gold Medal: Hugo Thienpont
In recognition of his profound and durable impact on society and pioneering vision for photonics. The different disruptive instruments that Thienpont has developed and implemented during the past decades have generated a tangible impact on education, research, innovation, and societal well-being in Flanders, across Europe, and beyond.

SPIE President's Award: Maria Yzuel
In recognition of her inspirational leadership in the field of optics; tireless dedication to the promotion of equity, diversity, and inclusion in science; and many years of outstanding service to SPIE and its international community.

SPIE Directors' Award: Maryellen Giger
In recognition of her outstanding service to SPIE and the optics and photonics communities. Giger has been a key voice in data-driven approaches, and an active leader in pushing forward our equity, diversity, and inclusion efforts.

SPIE Mozi Award: Xiang Zhang
In recognition of his seminal, fundamental contributions in optical physics and experimental research in the optical perfect lens.

SPIE Britton Chance Award in Biomedical Optics: Enrico Gratton
In recognition of a lifetime of contributions to the field of biomedical optics, including pioneering theoretical and instrumentation developments in fluorescence spectroscopy, fluorescence microscopy, and diffuse medical imaging.

SPIE Biophotonics Technology Innovator Award: Keisuke Goda
In recognition of his significant contributions to the field of biophotonics through the development of innovative ultrafast optical imaging and spectroscopy methods and their integration into microfluidic platforms.

SPIE A.E. Conrady Award in Optical Engineering: Dave Aikens
In recognition of his world-leading expertise, training programs, and development of optical engineering and optical standards.

SPIE Harrison H. Barrett Award in Medical Imaging: Kevin Berbaum
In recognition of more than three decades of dedication in the study of Satisfaction of Search, and significant contributions to receiver operating characteristic analysis.

SPIE Harold E. Edgerton Award in High-Speed Optics: Vladislav Yakovlev
In recognition of his remarkable contributions to ultrafast laser technology, ultrafast spectroscopies, and ultrafast imaging and their applications, as well as for his SPIE outreach.

SPIE Dennis Gabor Award in Diffractive Optics: Małgorzata Kujawińska
In recognition of her outstanding and manifold contributions to holographic technologies in optical metrology, optical imaging, and optical information processing, as well as for her extraordinary dedication to the SPIE community and widely recognized international leadership in applied optical engineering.

SPIE George W. Goddard Award in Space and Airborne Optics: Thomas Rimmele
In recognition of his invention and application of extended-source adaptive optics delivering diffraction-limited, high-resolution imaging of the solar surface.

SPIE G. G. Stokes Award in Optical Polarization: Nirmalya Ghosh
In recognition of his extensive research in the field of Mueller matrix polarimetry and applications of Mueller matrix polarimetric spectroscopy and imaging in various interdisciplinary fields including quantum optics, space optics, biomedical optics, chemistry, material science, and fluorescence spectroscopy.

SPIE Chandra S. Vikram Award in Optical Metrology: Krzysztof Patorski
In recognition of his seminal contributions to diffraction, interferometry, moiré fields, and fringe analysis with applications in optical metrology, experimental mechanics, and biomedical engineering.

SPIE Frits Zernike Award in Microlithography: Bruce Smith
In recognition of his many contributions as a researcher and leader in the microlithography community, and for his achievements in educating an entire generation of engineers who continue to advance academic research and industry understanding.

SPIE Diversity Outreach Award: Celine d'Orgeville
In recognition of her leadership in diversity, inclusion, and equity activities in Australia and elsewhere in the world.

SPIE Maria Goeppert-Mayer Award in Photonics: Jorge Ojeda-Castañeda
In recognition of his outstanding contributions to modern and advanced imaging technologies for the development of phase-space representations of imaging devices, which enable the design of innovative techniques for extending field depth, and for proposing novel designs employing lenses with tunable optical power.

SPIE Maiman Laser Award: Anne Tropper
In recognition of her pioneering contributions to rare-earth doped fiber and optically pumped semiconductor lasers.

SPIE Early Career Achievement Award — Academic Focus: Muyinatu Bell
In recognition of her pioneering contributions to photoacoustic imaging for surgical guidance, including innovative technology designs, novel deep learning applications, informative spatial coherence beamforming theory, and visionary clinical possibilities.

SPIE Early Career Achievement Award — Industry/Government Focus: Sergio Carbajo
In recognition of his capacity to unify ultrafast and quantum optics with X-ray science to advance the mission of Basic Energy Sciences facilities.

SPIE Maria J. Yzuel Educator Award: Bishnu Pal
In recognition of four decades of sustained contributions in education, outreach, research, technical program committees of global flagship conferences, and editing of four popular publications in guided wave optics and photonics.

SPIE Aden and Marjorie Meinel Technology Achievement Award: Shouleh Nikzad
In recognition of her pioneering and sustained contributions to the development of ultraviolet instrument technologies, especially imagers for space exploration and extension of their use in terrestrial applications.

The complete listing of all SPIE awards and recipients is available here .

About SPIE

SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves more than 258,000 constituents from 184 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2020, SPIE provided over $5.8 million in community support including scholarships and awards, outreach and advocacy programs, travel grants, public policy, and educational resources. www.spie.org .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release

If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis

Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release

This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw

Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release

New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra

Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release

Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e

Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release

Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye